bg
S

Sage Therapeutics (SAGE)

$000.00 0.00% ($0.00)

  • Today
  • Week
  • Month
  • Year
  • 5 Year
  • YTD

About Sage Therapeutics (SAGE)

SAGE Therapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in developing and commercializing medicines to treat central nervous system (CNS) disorders. The Company's lead product candidate, SAGE-547 is an intravenou... Read more

  • USD50.04
  • USD50.24
  • USD48.75
  • USD54.86
  • 1.30%
  • 9M
  • 133.83k
  • 455.33k
  • 3.0B
  • 30.67
  • 58.30%

Unlock More Stock Analysis & Reports

Access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.